Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-08

Clinical Trial Update: Precision Medicine Applied to the Study of Endometrial Cancer: Application of NGS for Molecular Classification

View source ↗

Summary

This clinical trial applies precision medicine and next-generation sequencing to molecularly classify endometrial cancer. The study status is NOT_YET_RECRUITING…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospital Italiano de Buenos Aires | Conditions: Endometrial Cancer, Endometrial Neoplasm | Status: NOT_YET_RECRUITING